Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim reported positive results from a similar phase 3 trial assessing its PDE4B ...

Triple T, a new minimally invasive therapy, could replace adrenal surgery for treating primary aldosteronism, a hidden cause ...

Eko Health developed an AI algorithm that, combined with noninvasive heart tests, may be able to accurately identify pulmonary hypertension.

The following is a summary of “Differences between private and public primary health care centers and differences between men and women in antihypertensive care and cardiovascular prevention in all ...

Participants with higher forced vital capacity, indicating better lung function, were less likely to develop heart disease, diabetes, and stroke over 10 years.

Inhibiting GLS1 reduced high blood pressure in the right side of the heart of PAH rats and improved various measures of heart ...

Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 millionReceived CE Mark for LungFit PH® in ...